Multistate nontyphoidal Salmonella and Shiga toxin-producing Escherichia coli outbreaks linked to international travel-United States, 2017-2020.

IF 2.5 4区医学 Q3 INFECTIOUS DISEASES Epidemiology and Infection Pub Date : 2024-01-11 DOI:10.1017/S0950268823002017

Caroline A Habrun, Meseret G Birhane, Louise K François Watkins, Katharine Benedict, Lyndsay Bottichio, Kaylea Nemechek, Beth Tolar, Morgan N Schroeder, Jessica C Chen, Hayat Caidi, Misha Robyn, Megin Nichols

{"title":"Multistate nontyphoidal Salmonella and Shiga toxin-producing Escherichia coli outbreaks linked to international travel-United States, 2017-2020.","authors":"Caroline A Habrun, Meseret G Birhane, Louise K François Watkins, Katharine Benedict, Lyndsay Bottichio, Kaylea Nemechek, Beth Tolar, Morgan N Schroeder, Jessica C Chen, Hayat Caidi, Misha Robyn, Megin Nichols","doi":"10.1017/S0950268823002017","DOIUrl":null,"url":null,"abstract":"Enteric bacterial infections are common among people who travel internationally. During 2017-2020, the Centers for Disease Control and Prevention investigated 41 multistate outbreaks of nontyphoidal Salmonella and Shiga toxin-producing Escherichia coli linked to international travel. Resistance to one or more antimicrobial agents was detected in at least 10% of isolates in 16 of 30 (53%) nontyphoidal Salmonella outbreaks and 8 of 11 (73%) Shiga toxin-producing E. coli outbreaks evaluated by the National Antimicrobial Resistance Monitoring System. At least 10% of the isolates in 14 nontyphoidal Salmonella outbreaks conferred resistance to one or more of the clinically significant antimicrobials used in human medicine. This report describes the epidemiology and antimicrobial resistance patterns of these travel-associated multistate outbreaks. Investigating illnesses among returned travellers and collaboration with international partners could result in the implementation of public health interventions to improve hygiene practices and food safety standards and to prevent illness and spread of multidrug-resistant organisms domestically and internationally.","PeriodicalId":11721,"journal":{"name":"Epidemiology and Infection","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10894901/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S0950268823002017","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Enteric bacterial infections are common among people who travel internationally. During 2017-2020, the Centers for Disease Control and Prevention investigated 41 multistate outbreaks of nontyphoidal Salmonella and Shiga toxin-producing Escherichia coli linked to international travel. Resistance to one or more antimicrobial agents was detected in at least 10% of isolates in 16 of 30 (53%) nontyphoidal Salmonella outbreaks and 8 of 11 (73%) Shiga toxin-producing E. coli outbreaks evaluated by the National Antimicrobial Resistance Monitoring System. At least 10% of the isolates in 14 nontyphoidal Salmonella outbreaks conferred resistance to one or more of the clinically significant antimicrobials used in human medicine. This report describes the epidemiology and antimicrobial resistance patterns of these travel-associated multistate outbreaks. Investigating illnesses among returned travellers and collaboration with international partners could result in the implementation of public health interventions to improve hygiene practices and food safety standards and to prevent illness and spread of multidrug-resistant organisms domestically and internationally.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

与国际旅行有关的多州非伤寒沙门氏菌和产志贺毒素大肠埃希氏菌爆发 - 美国，2017-2020 年。

肠道细菌感染在国际旅行者中很常见。2017-2020 年间，美国疾病控制和预防中心调查了 41 起与国际旅行有关的多州爆发的非伤寒沙门氏菌和产志贺毒素大肠杆菌疫情。在国家抗菌药耐药性监测系统（National Antimicrobial Resistance Monitoring System）评估的 30 起非伤寒沙门氏菌疫情中的 16 起（53%）和 11 起产志贺毒素大肠杆菌疫情中的 8 起（73%）中，至少有 10% 的分离菌株被检测出对一种或多种抗菌药产生耐药性。在 14 起非伤寒沙门氏菌疫情中，至少有 10% 的分离菌株对一种或多种临床上常用的抗菌药物产生耐药性。本报告介绍了这些与旅行相关的多州疫情的流行病学和抗菌药耐药性模式。对回国旅行者的疾病进行调查，并与国际伙伴合作，可以实施公共卫生干预措施，改善卫生习惯和食品安全标准，预防疾病和耐多药生物在国内和国际上的传播。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Epidemiology and Infection 医学-传染病学

CiteScore

4.10

自引率

2.40%

发文量

366

审稿时长

3-6 weeks

期刊介绍： Epidemiology & Infection publishes original reports and reviews on all aspects of infection in humans and animals. Particular emphasis is given to the epidemiology, prevention and control of infectious diseases. The scope covers the zoonoses, outbreaks, food hygiene, vaccine studies, statistics and the clinical, social and public-health aspects of infectious disease, as well as some tropical infections. It has become the key international periodical in which to find the latest reports on recently discovered infections and new technology. For those concerned with policy and planning for the control of infections, the papers on mathematical modelling of epidemics caused by historical, current and emergent infections are of particular value.